Literature DB >> 33492296

Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.

Daniel Cuervo-Zanatta1,2, Jaime Garcia-Mena2, Claudia Perez-Cruz1.   

Abstract

BACKGROUND: Normal aging is accompanied by cognitive deficiencies, affecting women and men equally. Aging is the main risk factor for Alzheimer's disease (AD), with women having a higher risk. The higher prevalence of AD in women is associated with the abrupt hormonal decline seen after menopause. However, other factors may be involved in this sex-related cognitive decline. Alterations in gut microbiota (GM) and its bioproducts have been reported in AD subjects and transgenic (Tg) mice, having a direct impact on brain amyloid-β pathology in male (M), but not in female (F) mice.
OBJECTIVE: The aim of this work was to determine GM composition and cognitive dysfunction in M and F wildtype (WT) and Tg mice, in a sex/genotype segregation design.
METHODS: Anxiety, short term working-memory, spatial learning, and long-term spatial memory were evaluated in 6-month-old WT and Tg male mice. Fecal short chain fatty acids were determined by chromatography, and DNA sequencing and bioinformatic analyses were used to determine GM differences.
RESULTS: We observed sex-dependent differences in cognitive skills in WT mice, favoring F mice. However, the cognitive advantage of females was lost in Tg mice. GM composition showed few sex-related differences in WT mice. Contrary, Tg-M mice presented a more severe dysbiosis than Tg-F mice. A decreased abundance of Ruminococcaceae was associated with cognitive deficits in Tg-F mice, while butyrate levels were positively associated with better working- and object recognition-memory in WT-F mice.
CONCLUSION: This report describes a sex-dependent association between GM alterations and cognitive impairment in a mice model of AD.

Entities:  

Keywords:  APP/PS1 mice; Anxiety; dysbiosis; high-throughput DNA sequencing; short-chain fatty acids; spatial memory; wildtype littermates

Year:  2021        PMID: 33492296     DOI: 10.3233/JAD-201367

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

Review 1.  The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease.

Authors:  Benita Wiatrak; Katarzyna Balon; Paulina Jawień; Dominika Bednarz; Izabela Jęśkowiak; Adam Szeląg
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

2.  Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes.

Authors:  Tauqeerunnisa Syeda; Mónica Sánchez-Tapia; Itzel Orta; Omar Granados-Portillo; Lizbeth Pérez-Jimenez; Juan-de-Dios Rodríguez-Callejas; Samuel Toribio; Maria-Del-Carmen Silva-Lucero; Ana-Leonor Rivera; Armando R Tovar; Nimbe Torres; Claudia Perez-Cruz
Journal:  Nutrients       Date:  2021-12-22       Impact factor: 5.717

3.  Predictive Value of Gut Microbiome for Cognitive Impairment in Patients with Hypertension.

Authors:  Shourong Lu; Lin Shao; Yunyun Zhang; Ying Yang; Zhuo Wang; Bingshan Zhang; Jie Yu; Qiao Xu; Shuqiang Wang; Xiaorong Chen; Zhiming Yu; Yilin Ren; Kan Hong
Journal:  Dis Markers       Date:  2021-10-06       Impact factor: 3.434

4.  Intestinal Flora Composition Determines Microglia Activation and Improves Epileptic Episode Progress.

Authors:  Xiaomi Ding; Jing Zhou; Li Zhao; Mingyue Chen; Shenglin Wang; Ming Zhang; Xiaodong Zhang; Guohui Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-03-09       Impact factor: 5.293

5.  Effects of Donepezil Treatment on Brain Metabolites, Gut Microbiota, and Gut Metabolites in an Amyloid Beta-Induced Cognitive Impairment Mouse Pilot Model.

Authors:  Jae-Kwon Jo; Gihyun Lee; Cong Duc Nguyen; Seong-Eun Park; Eun-Ju Kim; Hyun-Woo Kim; Seung-Ho Seo; Kwang-Moon Cho; Sun Jae Kwon; Jae-Hong Kim; Hong-Seok Son
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

Review 6.  Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions.

Authors:  Duygu Ağagündüz; Feray Gençer Bingöl; Elif Çelik; Özge Cemali; Çiler Özenir; Fatih Özoğul; Raffaele Capasso
Journal:  J Transl Med       Date:  2022-10-08       Impact factor: 8.440

Review 7.  Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment.

Authors:  Hui Li; Junjun Ni; Hong Qing
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.